Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366



 Company News
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada 7/24/2014 1:02:16 PM
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014 9:04:23 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIMâ„¢ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014 9:00:24 AM
Antibe Therapeutics Inc. Receives Approval From Health Canada To Begin Human Clinical Testing 6/19/2014 11:31:35 AM
Health Canada Approves Roche (RHHBY)'s HPV Test For First-Line Primary Screening Of Cervical Cancer And Roche Launches New Cytology Test To Provide The Most Comprehensive Portfolio For Cervical Cancer Screening 6/11/2014 9:19:58 AM
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review 6/3/2014 9:16:56 AM
AbbVie (ABBV) Files New Drug Submission To Health Canada For Its Investigational, All-Oral, Interferon-Free Therapy For The Treatment Of Hepatitis C 5/22/2014 9:31:26 AM
Antibe Therapeutics Inc. Announces Submission Of Clinical Trial Application To Health Canada For ATB-346 5/21/2014 9:48:39 AM
Helix Biopharma (CC:HBP) Submits L-DOS47 Clinical Trial Application With Health Canada 5/14/2014 9:51:51 AM
Health Canada Approves EGRIFTA™ (Tesamorelin For Injection) And Theratechnologies Inc. (TH.TO) Regains Canadian Commercialization Rights To EGRIFTA™ 4/30/2014 11:36:05 AM